GlassScriptPhysician profile
Leo H Eschbach
NPI 1194720581
$3,840.70
in general payments reported to CMS, 2019-2025
17 companies · $196 in 2025
The $196 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,504 · 2020: $732 · 2021: $764 · 2022: $425 · 2023: $91.92 · 2024: $129 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $416.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $666.08 | 2019 | |
| Abbvie INC. | $620.42 | 2019-2022 | |
| Amgen INC. | $487.77 | 2019-2025 | Evenity, Prolia, Prolia |
| Ethicon US, LLC | $427.65 | 2019-2021 | |
| Astellas Pharma US INC | $369.61 | 2019-2024 | Veozah |
| Pfizer INC. | $360.29 | 2019-2022 | |
| Myovant Sciences INC. | $216.99 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $178.00 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $109.07 | 2019-2025 | |
| Hologic Sales and Service, LLC | $103.12 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Amag Pharmaceuticals, INC. | $76.47 | 2019-2020 | |
| Evofem Biosciences, INC. | $76.03 | 2020-2025 | Phexxi, Solosec, Phexx |
| Sumitomo Pharma America, INC. | $49.62 | 2023-2025 | Myfembree, Gemtesa |
| Exact Sciences Corporation | $39.33 | 2025 | The Cologuard Plus Collection Kit |
| Allergan, INC. | $23.21 | 2019-2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $21.28 | 2025 | |
| Boston Scientific Corporation | $15.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leo Eschbach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.